Chardan Capital Markets Starts NOVONIX (NVX) at Buy
Tweet
Share
E-mailGet Alerts NVX Hot Sheet
Price: $0.44 +2.33%
Rating Summary:
1 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
1 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Chardan Capital Markets analyst Brian Dobson initiates coverage on NOVONIX (NASDAQ: NVX) with a Buy rating and a price target of $4.00.
For an analyst ratings summary and ratings history on NOVONIX click here. For more ratings news on NOVONIX click here.
Shares of NOVONIX closed at $1.98 yesterday.
You May Also Be Interested In
- Novonix adjusts ADS ratio to address Nasdaq price requirement
- RBC Capital Starts Krystal Biotech (KRYS) at Outperform
- Leerink Starts Ligand Pharma (LGND) at Outperform
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
